Atlas Trials

Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas

Clinical trial NCT04055220 · RECRUITING

Trial details

NCT number
NCT04055220
Sponsor
Centre Leon Berard
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Bone SarcomaOsteosarcomaEwing SarcomaChondrosarcomaUndifferentiated Pleomorphic SarcomaLeiomyosarcomaAngiosarcoma
Start date
2020-03-03
Primary completion
2026-10-01
Enrollment
168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.